Summary
The opportunity for the highly efficient recovery of immune receptor recombination data from cancer specimens, including the ready assessment of immune receptor V and J usage, raises the issue of establishing precise values of assessing the immune receptor status as opposed to obtaining basic information regarding lymphocyte infiltration, in the cancer setting. In this report, we obtained the lymphocyte infiltration percentages from the cancer digital slide archive representing uterine corpus endometrial carcinoma (UCEC) and correlated these data with recovery of the immune receptor recombination reads from corresponding UCEC exome files. Results indicated a basic correlation of the recovery of productive T-cell receptor beta (TRB) recombination reads with lymphocyte infiltration percentages. However, the recovery of specific immune receptor recombination reads did not indicate the same survival outcomes as microscope detection of lymphocyte infiltrate percentages. To further exploit the value of recovery of the TRB recombination reads from the UCEC exome files, we determined the survival outcomes for combinations of TRB gene segment usage and HLA class I alleles, with the most important result being that the combination of HLA-A*01:01 and TRB-J1 segment usage reflected a strikingly high survival rate. Overall, this report emphasized the increased value of the knowledge of the immune receptor recombinations, in comparison with basic lymphocyte infiltration percentages, in assessing cancer survival rates.
K E Y W O R D S
endometrial cancer, exome files, lymphocyte infiltrate, T-cell receptor, V(D)J Tong, Tu, Samy, Sexton, & Blanck, 2017; Tu et al., 2017) . The opportunity to detect specific immune receptor recombinations, including the V and J usage information, raises the question of whether such information would be more valuable than microscopic data regarding lymphocyte infiltration, and in particular, raises the question of whether distinct immune receptor recombinations might "substratify" cancer patients otherwise previously distinguished only on the basis of lymphocyte infiltration percentage? The results presented here not only indicate the knowledge of specific immune receptor recombinations indicates distinct prognoses, but also indicate a way to further stratify patients, with the benefit of additional, significant survival distinctions, in combining the V and J usage information with HLA class I types.
| ME THODS

| Obtaining WXS
To obtain WXS for the Cancer Genome Atlas (TCGA) UCEC samples, manifest files (Supporting Information Table S1 ) were downloaded from the Genomic Data Commons (GDC). The manifests were edited via a text editing application, Sublime Text, for the removal of duplicate UUIDs (file ID's) or duplicate TCGA barcodes (sample IDs); removal of sample types other than primary tumour; and for formatting needed to perform the download of WXS using the data transfer tool. For UCEC, not all files in the manifest were linked to the TCGA barcodes. Thus, a small script was written to gather the TCGA barcodes from the GDC metadata for the UUIDs where barcode information was lacking. Also, the manifest, as originally obtained from GDC, represented some duplicate barcodes. Thus, the final tally for beginning this study was 599 UCEC barcodes. However, a smaller tally is evident in various parts of the study due to files that could not be processed, presumably due to file formatting errors; and due to lack of corresponding data for all barcodes, for example, data retrieved from the cancer digital slide archive, discussed below.
| IMGT designations of recombination read validity
The WXS files were processed in two steps, using a BaSH script, as previously described (Callahan, Patel, Fawcett, & Blanck, 2017; Tong et al., 2017; Tu et al., 2017) , with the second step verifying the identity of a recombination read. For the purpose of this study, matches of 20 nucleotides or more, for the V and J segments, respectively, were considered a minimum standard for accepting the designation of the IMGT web tool. For example, if a given TRA recombination was identified as the recombination of a particular TRAV and particular TRAJ segment, in each case, a minimum of 20 nucleotides was needed for use of the read in subsequent analyses. Processing steps then assigned reads into categories based on IMGT outputs: productive recombination, unproductive recombination, no rearrangement, unknown rearrangement, unknown result or no result (Supporting Information Tables S2-S6).
| Pairing the cancer digital slide archive lymphocyte information with IMGT outputs
Each barcode was evaluated in the UCEC section of the CDSA for the lymphocyte infiltration. An Excel file was generated, matching the barcodes and lymphocyte infiltrate percentages, and this file was used to match lymphocyte infiltrate percentages with the barcodes representing the different categories of read recoveries, for example, barcodes representing recovery of productive TRB reads.
| Statistical analysis
Once barcodes had matching data from the CDSA, the barcodes were divided into a test group and two control groups. The test group was TRB productive (n = 205), while the controls were designated as "unknown rearrangement" (Supporting Information Table   S7 , where only barcodes which represented recovery of TRB productive recombinations reads were removed; n = 144) and "modified unknown rearrangement" (Supporting Information Table S8 , with removal of all identified recombinations; TRB productive, TRA productive, TRD productive, IGL productive and IGK productive; n = 96).
For the three groups (test groups and both controls), averages of the lymphocyte infiltration were obtained. Then, t tests were performed comparing the test group to both controls (Supporting Information   Table S9 ).
| Survival analysis
To determine the effect of lymphocyte infiltration on patient survival Kaplan-Meier (KM) analyses were conducted, using IBM statistical package for the social sciences (SPSS), as described (Callahan et al., 2017) . The KM curves were obtained for the UCEC barcode Table S10 ).
| HLA class I allele typing using the WXS files
The HLA class I allele types were obtained using the Optitype software (Szolek et al., 2014) exactly as described previously (Callahan et al., 2017) . Briefly, to determine the HLA class I type of each barcode (patient) in the TCGA UCEC dataset, we first downloaded the WXS from the GDC data portal, with approval via NIH dbGaP project number 6300. These files were downloaded to USF research computing using the GDC data transfer tool. Using Samtools, we then extracted chromosome six from the sequences for subsequent processing by the Optitype HLA class I typing software, yielding HLA-A, HLA-B and HLA-C alleles for each barcode (Supporting Information   Table S11 ).
| Supporting material
This project generated a large amount of supporting data, which can be provided as an organized PDF via email request to the corresponding author. The supporting data includes: the UCEC download manifest, an example output, barcode-match list for TRB the productive recombination reads for UCEC TRB; TRA, IGL and IGK.
Also included are the barcodes representing the "unknown rearrangement" (control category); and the "modified unknown rearrangement" (control category), per Section 3; statistical analyses of test and control categories; SPSS KM curve outputs; barcodes for HLA analyses; HLA KM curves from the cbioportal.org web tool; recombination read barcodes as a matchup with UCEC subtypes; and the distribution of barcodes with immune receptor recombinations, including the control barcode sets, across UCEC subtypes.
| RE SULTS
To determine whether microscope-determined, lymphocyte infiltration percentages from CDSA mirrored the recovery of immune receptor recombination reads from UCEC WXS files, we obtained the lymphocyte percentages, where available, for each barcode (patient sample) from the CDSA, and we recovered the immune receptor recombination reads from 599 TCGA UCEC WXS files, as previously described (Gill et al., 2016; Tong et al., 2017; Tu et al., 2017 ; Section 2). The UCEC WXS files were searched for TRA, TRB, TRD, and IGL and IGK recombinations, using a two-step process. In the first step, candidate 
To determine the relationship between lymphocyte infiltration
and UCEC patient survival, we assembled KM curves, as follows.
The UCEC barcodes were sorted based on lymphocyte infiltration and divided into top and bottom 10%, 20%, 30%, 40% and 50%.
The barcodes in the top percentages were compared to those in the matching bottom percentage. For example, the top 20% of barcodes, for lymphocyte infiltration, were compared to the bottom 20%. The KM analyses indicated that higher percentages of lymphocytes were associated with decreased overall survival (Figure 2a) . The survival was significantly worse for barcodes that were in the top 40th and 50th percentile of lymphocyte infiltration for the whole UCEC TRB set when compared to the bottom 40th and 50th percentile for the same set of barcodes. Barcodes in the top 10th, 20th and 30th percentile of lymphocyte infiltration of the UCEC TRB set had survival curves which trended worse than those in the bottom 10th, 20th and 30th percentiles.
Kaplan-Meier curves were constructed for the test group (productive TRB), the control groups from the first analysis (unknown rearrangement and unknown rearrangements with the removal of identified recombinations, termed, modified unknown rearrangements). The KM curve comparing the unknown rearrangement, negative control group to UCEC productive TRB showed significantly better survival for the barcodes in the productive group, p-value 0.027 (Figure 2b ). While the comparison of the modified unknown rearrangement, negative control group to the UCEC productive TRB group did not yield a significant F I G U R E 1 Average percentage of lymphocyte infiltrates for uterine corpus endometrial carcinoma barcodes representing the recovery of recombination reads for productive TRB, the test group; unknown rearrangements, the first control group; and modified unknown rearrangements, the second control group. The two control groups are further defined in Sections 2 and 3 p-value, the KM survival curve was similar to that for the preceding, negative control versus productive TRB comparison (Figure 2c) , with the productive TRB, and trended towards better survival.
We then generated KM curves for the immunoglobulin-related barcodes, which showed that barcodes representing either productive IGL or IGK were significantly more likely to represent longer survival than the barcodes lacking either (p-value: 0.042; Figure 3a) .
Similarly, we found that barcodes representing both productive TRA and TRB (codetection within one barcode WXS) were significantly more likely to represent longer survival than the barcodes that did not represent TRA and TRB codetection (Figure 3b ).
To illustrate another layer of analysis made possible by performing recombination read recoveries, HLA typing for the UCEC WXS files was conducted, exactly as described (Callahan et al., 2017; Szolek et al., 2014) . The HLA class I allele typing data, in combination with the knowledge of the TRBJ segment groups (J1 or J2 groups), revealed that the combination of TRBJ1 and HLA-A*01:01 had a significantly higher rate of disease-free survival when compared to all remaining barcodes (p < 0.014; Supporting Information Table S12, TRBJ usage, HLA allele KM curves from cbioportal.org web tool). In fact, over the time period studied, 100% of this group was disease-free and surviving, whereas about 60% of the all remaining group was disease-free and surviving. Also, the HLA-A*01:01 group had no significant disease-free survival distinction, in comparison with all remaining barcodes (Supporting Information Table S12 ). The TRBJ1 group, independently of HLA class I type, did have a significant disease-free survival difference with the all remaining set (p < 0.024; Supporting Information Table S12). However, over the time period studied, the TRBJ1 group had 80% disease-free and surviving versus 60% for all remaining barcodes. Thus, the diseasefree survival value of the TRBJ1/HLA-A*0101 combination is greater than the disease-free survival value of TRBJ1 alone.
The barcode group with TRBJ1/HLA-A*03:01 showed significantly worse overall survival when compared to all remaining barcodes (p < 0.0077; Supporting Information Table S12 ). As noted above, the TRBJ1 group alone had a greater disease-free survival value, but the TRBJ1 group did not have a significant overall survival increase compared to all remaining barcodes, although there was a trend in that direction. The HLA-A*03:01 group (in total) also did not have a significant survival difference, in comparison with all remaining barcodes, but did trend in the direction of worse survival. In sum, the above two examples of TRBJ usage, in combination with HLA class I alleles, indicated specific survival outcomes in this UCEC dataset. F I G U R E 2 (a) Uterine corpus endometrial carcinoma (UCEC) barcode group representing the top 50% levels of lymphocyte infiltration (arrow) compared to UCEC barcode group representing the bottom 50% levels of lymphocyte infiltration (p = 0.0087). Comparisons of other percentile distinctions are available upon email request to corresponding author (Section 2). (b) UCEC barcode group representing recovery of productive TRB recombination reads (arrow) compared to UCEC unknown rearrangements (p = 0.027). (c) UCEC barcode group with TRB productive recombination reads (arrow) compared to UCEC barcode group with modified unknown rearrangements (p = 0.127)
| D ISCUSS I ON
The above data clearly indicate distinctions between the information obtained with basic lymphocyte infiltration percentages and the recovery of immune receptor V(D)J recombination reads. In addition, it is apparent that information from the recovery of recombination reads, at least for those representing the TRB immune receptor gene, can be augmented by knowledge of the HLA class I alleles, for the patient for whom the tumour resident TRB recombinations have been assessed. The increased value and precision of stratifying patients based on both the tumour resident TRB gene segment usage, and the HLA alleles, including HLA class II alleles, are consistent with other work from our group Callahan, Yavorski, et al., 2018) . There is a cautionary consideration for these assessments, in that replicate data sets are not likely to ever be available, in that replication of the 599 patient tumours subject to the above analyses would require replication of the HLA allele distribution and treatment protocols, among many There are many instances, and a large amount of data (Cai et al., 2015; Demaria et al., 2010; Dennis et al., 2013; Dulai, Sandborn, & Gupta, 2016; Fornaro et al., 2016; Grivennikov, Greten, & Karin, 2010; McLean et al., 2011; Pal et al., 2014; Romaniuk & Lуndіn, 2015; Viac, Bustamante, & Thivolet, 1977; Westbrook, Szakmary, & Schiestl, 2010) , supporting the conclusion that inflammation is associated with cancer development, including in the case of endometrial carcinoma (Berstein, 2017; Trabert et al., 2017) . However, given the association of a good prognosis with the above recovery of TRB recombination reads, as well as with other immune receptor recombination reads, the question becomes, which type of lymphocytes is associated with a poor prognosis? There are numerous potential answers, particularly from the standpoint of certain regulatory lymphocytes that would not have been identified in the above study. However, it is notable that the UCEC samples have yet to be processed for recombination reads representing γ/δT cells, associated with a negative outcome in many other cancer settings (Ke, Kapp, & Kapp, 2003; Lafont et al., 2014; Peng et al., 2007; Seo, Tokura, Takigawa, & Egawa, 1999; Silva-Santos, Serre, & Norell, 2015) . There has yet to be any assessment of γ/δT cells and UCEC.
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